Found: 30
Select item for more details and to access through your institution.
Preliminary safety and efficacy data of brecanavir, a novel HIV-1 protease inhibitor: 24 week data from study HPR10006.
- Published in:
- Journal of Antimicrobial Chemotherapy (JAC), 2007, v. 60, n. 1, p. 170, doi. 10.1093/jac/dkm122
- By:
- Publication type:
- Article
HIV-1 attachment inhibitor prodrug BMS-663068 in antiretroviral-experienced subjects: week 24 sub-group analysis.
- Published in:
- Journal of the International AIDS Society, 2014, v. 17, p. n/a, doi. 10.7448/IAS.17.4.19529
- By:
- Publication type:
- Article
Safety profile of HIV-1 attachment inhibitor prodrug BMS-663068 in antiretroviral-experienced subjects: week 24 analysis.
- Published in:
- Journal of the International AIDS Society, 2014, v. 17, p. n/a, doi. 10.7448/IAS.17.4.19530
- By:
- Publication type:
- Article
Restoration of Blood Total Glutathione Status and Lymphocyte Function Following -Lipoic Acid Supplementation in Patients with HIV Infection.
- Published in:
- Journal of Alternative & Complementary Medicine, 2008, v. 14, n. 2, p. 139, doi. 10.1089/acm.2006.6397
- By:
- Publication type:
- Article
Zalcitabine compared with zidovudine in patients with advanced HIV-1 infection who received previous zidovudine therapy.
- Published in:
- 1993
- By:
- Publication type:
- journal article
Phase 2 gene therapy trial of an anti-HIV ribozyme in autologous CD34<sup>+</sup> cells.
- Published in:
- Nature Medicine, 2009, v. 15, n. 3, p. 285, doi. 10.1038/nm.1932
- By:
- Publication type:
- Article
T-1249 Retains Potent Antiretroviral Activity in Patients Who Had Experienced Virological Failure while on an Enfuvirtide-Containing Treatment Regimen.
- Published in:
- Journal of Infectious Diseases, 2005, v. 191, n. 7, p. 1155
- By:
- Publication type:
- Article
Loss of Cytomegalovirus-Specific CD4[sup+] T Cell Responses in Human Immunodeficiency Virus Type 1-Infected Patients with High CD4[sup+] T Cell Counts and Recurrent Retinitis.
- Published in:
- Journal of Infectious Diseases, 2001, v. 183, n. 8, p. 1285
- By:
- Publication type:
- Article
The Safety and Efficacy of Adefovir Dipivoxil, a Novel Anti-Human Immunodeficiency Virus (HIV) Therapy, in HIV-Infected Adults: A Randomized, Double-Blind, Placebo-Controlled Trial.
- Published in:
- Journal of Infectious Diseases, 1997, v. 176, n. 6, p. 1517
- By:
- Publication type:
- Article
A Randomized, Double-Blind, Placebo-Controlled Trial of Cidofovir Gel for the Treatment of Acyclovir-Unresponsive Mucocutaneous Herpes Simplex Virus Infection in Patients with AIDS.
- Published in:
- Journal of Infectious Diseases, 1997, v. 176, n. 4, p. 892
- By:
- Publication type:
- Article
Evolution of Mutations Conferring Multidrug Resistance during Prophylaxis and Therapy for Cytomegalovirus Disease.
- Published in:
- Journal of Infectious Diseases, 1997, v. 176, n. 3, p. 786
- By:
- Publication type:
- Article
Antiretroviral Monotherapy in Early Stage Human Immunodeficiency Virus Disease Has No Detectable Effect on Virus Load in Peripheral Blood and Lymph Nodes.
- Published in:
- Journal of Infectious Diseases, 1996, v. 173, n. 4, p. 849, doi. 10.1093/infdis/173.4.849
- By:
- Publication type:
- Article
Pharmacokinetic, Safety, and Antiviral Profiles of Oral Ganciclovir in Persons Infected with Human Immunodeficiency Virus: A Phase I/II Study.
- Published in:
- Journal of Infectious Diseases, 1995, v. 171, n. 6, p. 1431, doi. 10.1093/infdis/171.6.1431
- By:
- Publication type:
- Article
Treatment With Intravenous (S)-1-[3-Hydroxy-2-(Phosphonylmethoxy)Propyl]-Cytosine Of Acyclovir-Resistant Mucocutaneous Infection With Herpes Simplexvirus In A Patient With Aids.
- Published in:
- Journal of Infectious Diseases, 1994, v. 170, n. 3, p. 570
- By:
- Publication type:
- Article
Immunogenicity and Safety of 13-Valent Pneumococcal Conjugate Vaccine in HIVInfected Adults Previously Vaccinated With Pneumococcal Polysaccharide Vaccine.
- Published in:
- Journal of Infectious Diseases, 2015, v. 212, n. 1, p. 18, doi. 10.1093/infdis/jiu631
- By:
- Publication type:
- Article
Anti-HIV-1 Activity of Weekly or Biweekly Treatment with Subcutaneous PRO 140, a CCR5 Monoclonal Antibody.
- Published in:
- Journal of Infectious Diseases, 2010, v. 201, n. 10, p. 1481, doi. 10.1086/652190
- By:
- Publication type:
- Article
Safety, Pharmacokinetics, and Antiviral Activity of HGSOO4, a Novel Fully Human IgG4 Monoclonal Antibody against CCR5, in H1V-1—Infected Patients.
- Published in:
- Journal of Infectious Diseases, 2008, v. 197, n. 5, p. 721, doi. 10.1086/527327
- By:
- Publication type:
- Article
Assessment of Drug-drug Interaction Potential of Enfuvirtide in Human Immunodeficiency Virus Type 1-infected Patients<sup>*</sup>.
- Published in:
- Clinical Pharmacology & Therapeutics, 2004, v. 75, n. 6, p. 558, doi. 10.1016/j.clpt.2004.02.003
- By:
- Publication type:
- Article
Assessment of Metabolic Inhibition Potential of Enfuvirtide Using a 5-Drug Cocktail in HIV-1 Infected Patients.
- Published in:
- Clinical Pharmacology & Therapeutics, 2003, v. 73, n. 2, p. P81, doi. 10.1016/S0009-9236(03)90658-8
- By:
- Publication type:
- Article
On-treatment HCV RNA as a predictor of sustained virological response in HCV genotype 3-infected patients treated with daclatasvir and sofosbuvir.
- Published in:
- Liver International, 2016, v. 36, n. 11, p. 1611, doi. 10.1111/liv.13165
- By:
- Publication type:
- Article
Maraviroc.
- Published in:
- 2007
- By:
- Publication type:
- Editorial
Enfuvirtide: A Viewpoint by Jacob Lalezari.
- Published in:
- Drugs, 2003, v. 63, n. 24, p. 2767, doi. 10.2165/00003495-200363240-00007
- By:
- Publication type:
- Article
Intravenous cidofovir for peripheral cytomegalovirus retinitis in patients with AIDS.
- Published in:
- Annals of Internal Medicine, 1997, v. 126, n. 4, p. 257, doi. 10.7326/0003-4819-126-4-199702150-00001
- By:
- Publication type:
- Article
TORO: Ninety-Six-Week Virologic and Immunologic Response and Safety Evaluation of Enfuvirtide with an Optimized Background of Antiretrovirals.
- Published in:
- AIDS Patient Care & STDs, 2007, v. 21, n. 8, p. 533, doi. 10.1089/apc.2006.0174
- By:
- Publication type:
- Article
EDP-514 in healthy subjects and nucleos(t)ide reverse transcriptase inhibitor-suppressed patients with chronic hepatitis B.
- Published in:
- Antiviral Therapy, 2022, v. 27, n. 6, p. 1, doi. 10.1177/13596535221127848
- By:
- Publication type:
- Article
Histone Deacetylase Inhibitor Romidepsin Induces HIV Expression in CD4 T Cells from Patients on Suppressive Antiretroviral Therapy at Concentrations Achieved by Clinical Dosing.
- Published in:
- PLoS Pathogens, 2014, v. 10, n. 4, p. 1, doi. 10.1371/journal.ppat.1004071
- By:
- Publication type:
- Article
Daclatasvir in Combination With Asunaprevir and Beclabuvir for Hepatitis C Virus Genotype 1 Infection With Compensated Cirrhosis.
- Published in:
- JAMA: Journal of the American Medical Association, 2015, v. 313, n. 17, p. 1736, doi. 10.1001/jama.2015.3868
- By:
- Publication type:
- Article
Sofosbuvir and Ribavirin for Hepatitis C in Patients With HIV Coinfection.
- Published in:
- JAMA: Journal of the American Medical Association, 2014, v. 312, n. 4, p. 353, doi. 10.1001/jama.2014.7734
- By:
- Publication type:
- Article
TURQUOISE-I Part 1b: Ombitasvir/Paritaprevir/Ritonavir and Dasabuvir with Ribavirin for Hepatitis C Virus Infection in HIV-1 Coinfected Patients on Darunavir.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Safety and Immunogenicity of a Replication-Incompetent Adenovirus Type 5 HIV-1 Clade B gag/pol/nef Vaccine in Healthy Adults.
- Published in:
- Clinical Infectious Diseases, 2008, v. 46, n. 11, p. 1769, doi. 10.1086/587993
- By:
- Publication type:
- Article